The zebrafish model of tuberculosis - no lungs needed

References

• Laboratory biosafety manual. World Health Organization. 1995. Ann Ist Super Sanita. 31:1–121.
   Google Scholar
• Adams KN, Szumowski JD, Ramakrishnan L. 2014. Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs. J Infect Dis. 210:456–466.
   PubMed Web of Science ®Google Scholar
• Adams KN, Takaki K, Connolly LE, Wiedenhoft H, Winglee K, Humbert O, Edelstein PH, Cosma CL, Ramakrishnan L. 2011. Drug tolerance in replicating Mycobacteria mediated by a macrophage-induced efflux mechanism. Cell. 145:39–53.
   PubMed Web of Science ®Google Scholar
• Aggad D, Mazel M, Boudinot P, Mogensen KE, Hamming OJ, Hartmann R, Kotenko S, Herbomel P, Lutfalla G, Levraud JP. 2009. The two groups of zebrafish virus-induced interferons signal via distinct receptors with specific and shared chains. J Immunol. 183:3924–3931.
   PubMed Web of Science ®Google Scholar
• Ali S, Champagne DL, Spaink HP, Richardson MK. 2011. Zebrafish embryos and larvae: a new generation of disease models and drug screens. Birth Defects Res C Embryo Today. 93:115–133. English.
   PubMedGoogle Scholar
• Armstrong JA, Hart PD. 1971. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med. 134:713.
   PubMed Web of Science ®Google Scholar
• Aspatwar A, Hammaren M, Koskinen S, Luukinen B, Barker H, Carta F, Supuran CT, Parikka M, Parkkila S. 2017 . β-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis. J Enzyme Inhib Med Chem. 32:832–840.
   PubMed Web of Science ®Google Scholar
• Capelle P, Dhumeaux D, Mora M, Feldmann G, Berthelot P. 1972. Effect of rifampicin on liver function in man. Gut. 13:366–371.
   PubMed Web of Science ®Google Scholar
• Carvalho R, de Sonneville J, Stockhammer OW, Savage ND, Veneman WJ, Ottenhoff TH, Dirks RP, Meijer AH, Spaink HP. 2011. A high-throughput screen for tuberculosis progression. PLoS One. 6:e16779.
   PubMed Web of Science ®Google Scholar
• Chae YK, Arya A, Malecek MK, Shin DS, Carneiro B, Chandra S, Kaplan J, Kalyan A, Altman JK, Platanias L, et al. 2016. Repurposing metformin for cancer treatment: current clinical studies. Oncotarget. 7:40767–40780.
   PubMed Web of Science ®Google Scholar
• Chaudhari GH, Chennubhotla KS, Chatti K, Kulkarni P. 2013. Optimization of the adult zebrafish ECG method for assessment of drug-induced QTc prolongation. J Pharmacol Toxicol Methods. 67:115–120.
   PubMed Web of Science ®Google Scholar
• Clay H, Davis JM, Beery D, Huttenlocher A, Lyons SE, Ramakrishnan L. 2007. Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish. Cell Host Microbe. 2:29–39.
   PubMed Web of Science ®Google Scholar
• Cornet C, Calzolari S, Minana-Prieto R, Dyballa S, van Doornmalen E, Rutjes H, Savy T, D'Amico D, Terriente J. 2017. ZeGlobalTox: an innovative approach to address organ drug toxicity using zebrafish. IJMS. 18:864.
   Web of Science ®Google Scholar
• Crim MJ, Riley LK. 2012. Viral diseases in zebrafish: what is known and unknown. Ilar J. 53:135–143.
   PubMed Web of Science ®Google Scholar
• Cui Z, Samuel-Shaker D, Watral V, Kent ML. 2010. Attenuated Mycobacterium marinum protects zebrafish against mycobacteriosis. J Fish Dis. 33:371–375.
   PubMed Web of Science ®Google Scholar
• Dalton JP, Uy B, Okuda KS, Hall CJ, Denny WA, Crosier PS, Swift S, Wiles S. 2017. Screening of anti-mycobacterial compounds in a naturally infected zebrafish larvae model. J Antimicrob Chemother. 72:421–427.
   PubMed Web of Science ®Google Scholar
• Dannenberg AM. Jr. 1993. Immunopathogenesis of pulmonary tuberculosis. Hosp Pract (off Ed). 28:51–58.
   PubMed Web of Science ®Google Scholar
• Davis JM, Ramakrishnan L. 2009. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell. 136:37–49.
   PubMed Web of Science ®Google Scholar
• Desforges JF, Barnes PF, Bloch AB, Davidson PT, Snider DE. Jr. 1991. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 324:1644–1650.
   PubMed Web of Science ®Google Scholar
• Devi PB, Sridevi JP, Kakan SS, Saxena S, Jeankumar VU, Soni V, Anantaraju HS, Yogeeswari P, Sriram D. 2015. Discovery of novel lysine ɛ-aminotransferase inhibitors: an intriguing potential target for latent tuberculosis. Tuberculosis (Edinb). 95:786–794.
   PubMed Web of Science ®Google Scholar
• Driessen M, Vitins AP, Pennings JL, Kienhuis AS, Water B, van der Ven LT. 2015. A transcriptomics-based hepatotoxicity comparison between the zebrafish embryo and established human and rodent in vitro and in vivo models using cyclosporine A, amiodarone and acetaminophen. Toxicol Lett. 232:403–412.
   PubMed Web of Science ®Google Scholar
• Goessling W, North TE, Loewer S, Lord AM, Lee S, Stoick-Cooper CL, Weidinger G, Puder M, Daley GQ, Moon RT, et al. 2009. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell. 136:1136–1147.
   PubMed Web of Science ®Google Scholar
• Goody MF, Sullivan C, Kim CH. 2014. Studying the immune response to human viral infections using zebrafish. Dev Comp Immunol. 46:84–95.
   PubMed Web of Science ®Google Scholar
• Grosset J, Leventis S. 1983. Adverse effects of rifampin. Rev Infect Dis. 5 Suppl 3:S440–S450.
   PubMedGoogle Scholar
• Gupta P, Khobragade SB, Shingatgeri VM. 2014. Effect of various antiepileptic drugs in zebrafish PTZ-seizure model. Indian J Pharm Sci. 76:157–163.
   PubMed Web of Science ®Google Scholar
• Gut P, Baeza-Raja B, Andersson O, Hasenkamp L, Hsiao J, Hesselson D, Akassoglou K, Verdin E, Hirschey MD, Stainier DY. 2013. Whole-organism screening for gluconeogenesis identifies activators of fasting metabolism. Nat Chem Biol. 9:97–104.
   PubMed Web of Science ®Google Scholar
• Hall CJ, Wicker SM, Chien AT, Tromp A, Lawrence LM, Sun X, Krissansen GW, Crosier KE, Crosier PS. 2014. Repositioning drugs for inflammatory disease - fishing for new anti-inflammatory agents. Dis Model Mech. 7:1069–1081.
   PubMed Web of Science ®Google Scholar
• He JH, Guo SY, Zhu F, Zhu JJ, Chen YX, Huang CJ, Gao JM, Dong QX, Xuan YX, Li CQ. 2013. A zebrafish phenotypic assay for assessing drug-induced hepatotoxicity. J Pharmacol Toxicol Methods. 67:25–32.
   PubMed Web of Science ®Google Scholar
• Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, Collins JE, Humphray S, McLaren K, Matthews L, et al. 2013. The zebrafish reference genome sequence and its relationship to the human genome. Nature. 496:498–503.
   PubMed Web of Science ®Google Scholar
• Huiting LN, Laroche F, Feng H. 2015. The zebrafish as a tool to cancer drug discovery. Austin J Pharmacol Ther. 3:1069.
   PubMedGoogle Scholar
• Jan Z, Martin D. 2017. Old drugs and new targets as an outlook for the treatment of tuberculosis. Curr Med Chem. 24:1–26.
   Google Scholar
• Johansen MD, Hortle E, Kasparian JA, Romero A, Novoa B, Figueras A, Britton WJ, Silva K, Purdie AC, Oehlers SH. Analysis of mycobacterial infection-induced changes to host lipid metabolism in a zebrafish infection model reveals a conserved role for LDLR in infection susceptibility bioRxiv.
   Google Scholar
• Kantae V, Krekels EHJ, Ordas A, Gonzalez O, van Wijk RC, Harms AC, Racz PI, van der Graaf PH, Spaink HP, Hankemeier T. 2016. Pharmacokinetic modeling of paracetamol uptake and clearance in zebrafish larvae: expanding the allometric scale in vertebrates with five orders of magnitude. Zebrafish. 13:504–510.
   PubMed Web of Science ®Google Scholar
• Kinkel MD, Eames SC, Philipson LH, Prince VE. 2010. Intraperitoneal injection into adult zebrafish. J Vis Exp. 2126.
   PubMedGoogle Scholar
• Kulkarni P, Chaudhari GH, Sripuram V, Banote RK, Kirla KT, Sultana R, Rao P, Oruganti S, Chatti K. 2014. Oral dosing in adult zebrafish: proof-of-concept using pharmacokinetics and pharmacological evaluation of carbamazepine. Pharmacol Rep. 66:179–183.
   PubMed Web of Science ®Google Scholar
• Langenau DM, Ferrando AA, Traver D, Kutok JL, Hezel JP, Kanki JP, Zon LI, Look AT, Trede NS. 2004. In vivo tracking of T cell development, ablation, and engraftment in transgenic zebrafish. Proc Natl Acad Sci USA. 101:7369–7374.
   PubMed Web of Science ®Google Scholar
• Lin PL, Dietrich J, Tan E, Abalos RM, Burgos J, Bigbee C, Bigbee M, Milk L, Gideon HP, Rodgers M, et al. 2012. The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. J Clin Invest. 122:303–314.
   PubMed Web of Science ®Google Scholar
• MacRae CA, Peterson RT. 2015. Zebrafish as tools for drug discovery. Nat Rev Drug Discov. 14:721–731.
   PubMed Web of Science ®Google Scholar
• Maes J, Verlooy L, Buenafe OE, de Witte PA, Esguerra CV, Crawford AD. 2012. Evaluation of 14 organic solvents and carriers for screening applications in zebrafish embryos and larvae. PLoS One. 7:e43850.
   PubMed Web of Science ®Google Scholar
• Makarov V, Lechartier B, Zhang M, Neres J, Sar AM, Raadsen SA, Hartkoorn RC, Ryabova OB, Vocat A, Decosterd LA, et al. 2014. Towards a new combination therapy for tuberculosis with next generation benzothiazinones. EMBO Mol Med. 6:372–383.
   PubMed Web of Science ®Google Scholar
• Malapati P, Krishna VS, Nallangi R, Srilakshmi RR, Sriram D. 2018. Identification and development of benzoxazole derivatives as novel bacterial glutamate racemase inhibitors. Eur J Med Chem. 145:23–34.
   PubMed Web of Science ®Google Scholar
• Meijer AH. 2016. Protection and pathology in TB: learning from the zebrafish model. Semin Immunopathol. 38:261–273.
   PubMed Web of Science ®Google Scholar
• Mione MC, Trede NS. 2010. The zebrafish as a model for cancer. Dis Model Mech. 3:517–523.
   PubMed Web of Science ®Google Scholar
• Mitchell VP. 2018. Emerging understanding of tuberculosis and the granuloma by comparative analysis in humans, cattle, zebrafish, and nonhuman primates. Vet Pathol. 55:8–10.
   PubMed Web of Science ®Google Scholar
• Myllymaki H, Bauerlein CA, Ramet M. 2016. The zebrafish breathes new life into the study of tuberculosis. Front Immunol. 7:196.
   PubMed Web of Science ®Google Scholar
• Myllymaki H, Niskanen M, Luukinen H, Parikka M, Ramet M. 2018. Identification of protective postexposure mycobacterial vaccine antigens using an immunosuppression-based reactivation model in the zebrafish. Dis Model Mech. 11:dmm033175.
   PubMed Web of Science ®Google Scholar
• Myllymaki H, Niskanen M, Oksanen KE, Ramet M. 2015. Animal models in tuberculosis research - where is the beef?. Expert Opin Drug Discov. 10:871–883.
   PubMed Web of Science ®Google Scholar
• Myllymaki H, Niskanen M, Oksanen KE, Sherwood E, Ahava M, Parikka M, Ramet M. 2017. Identification of novel antigen candidates for a tuberculosis vaccine in the adult zebrafish (Danio rerio). PLoS One. 12:e0181942.
   PubMed Web of Science ®Google Scholar
• North TE, Babu IR, Vedder LM, Lord AM, Wishnok JS, Tannenbaum SR, Zon LI, Goessling W. 2010. PGE2-regulated wnt signaling and N-acetylcysteine are synergistically hepatoprotective in zebrafish acetaminophen injury. Proc Natl Acad Sci USA. 107:17315–17320.
   PubMed Web of Science ®Google Scholar
• Oehlers SH, Cronan MR, Scott NR, Thomas MI, Okuda KS, Walton EM, Beerman RW, Crosier PS, Tobin DM. 2015. Interception of host angiogenic signalling limits mycobacterial growth. Nature. 517:612–615.
   PubMed Web of Science ®Google Scholar
• Oksanen KE, Halfpenny NJ, Sherwood E, Harjula SK, Hammaren MM, Ahava MJ, Pajula ET, Lahtinen MJ, Parikka M, Ramet M. 2013. An adult zebrafish model for preclinical tuberculosis vaccine development. Vaccine. 31:5202–5209.
   PubMed Web of Science ®Google Scholar
• Ordas A, Raterink R-J, Cunningham F, Jansen HJ, Wiweger MI, Jong-Raadsen S, Bos S, Bates RH, Barros D, Meijer AH, et al. 2015. Testing tuberculosis drug efficacy in a zebrafish high-throughput translational medicine screen. Antimicrob Agents Chemother. 59:753–762.
   PubMed Web of Science ®Google Scholar
• Parikka M, Hammaren MM, Harjula SK, Halfpenny NJ, Oksanen KE, Lahtinen MJ, Pajula ET, Iivanainen A, Pesu M, Ramet M. 2012. Mycobacterium marinum causes a latent infection that can be reactivated by gamma irradiation in adult zebrafish. PLoS Pathog. 8:e1002944.
   PubMed Web of Science ®Google Scholar
• Passeri MJ, Cinaroglu A, Gao C, Sadler KC. 2009. Hepatic steatosis in response to acute alcohol exposure in zebrafish requires sterol regulatory element binding protein activation. Hepatology. 49:443–452.
   PubMed Web of Science ®Google Scholar
• Peal DS, Mills RW, Lynch SN, Mosley JM, Lim E, Ellinor PT, January CT, Peterson RT, Milan DJ. 2011. Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen. Circulation. 123:23–U74.
   PubMed Web of Science ®Google Scholar
• Pozos TC, Ramakrishnan L, Ramakrishan L. 2004. New models for the study of Mycobacterium-host interactions. Curr Opin Immunol. 16:499–505.
   PubMed Web of Science ®Google Scholar
• Prouty MG, Correa NE, Barker LP, Jagadeeswaran P, Klose KE. 2003. Zebrafish-Mycobacterium marinum model for mycobacterial pathogenesis. Fems Microbiol Lett. 225:177–182.
   PubMed Web of Science ®Google Scholar
• Pruvot B, Jacquel A, Droin N, Auberger P, Bouscary D, Tamburini J, Muller M, Fontenay M, Chluba J, Solary E. 2011. Leukemic cell xenograft in zebrafish embryo for investigating drug efficacy. Haematologica. 96:612–616.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan L. 2013. The zebrafish guide to tuberculosis immunity and treatment. Cold Spring Harb Symp Quant Biol. 78:179–192.
   PubMedGoogle Scholar
• Ramappa V, Aithal GP. 2013. Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management. J Clin Exp Hepatol. 3:37–49.
   PubMedGoogle Scholar
• Rubinstein AL. 2003. Zebrafish: from disease modeling to drug discovery. Curr Opin Drug Discov Devel. 6:218–223.
   PubMed Web of Science ®Google Scholar
• Russell DG, Barry CE, 3rd, Flynn JL. 2010. Tuberculosis: what we don't know can, and does, hurt us. Science. 328:852–856.
   PubMed Web of Science ®Google Scholar
• Russell DG, Cardona PJ, Kim MJ, Allain S, Altare F. 2009. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol. 10:943–948.
   PubMed Web of Science ®Google Scholar
• Santoriello C, Zon LI. 2012. Hooked! modeling human disease in zebrafish. J Clin Invest. 122:2337–2343.
   PubMed Web of Science ®Google Scholar
• Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB, et al. 2006. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 174:935–952.
   PubMed Web of Science ®Google Scholar
• Scales MD, Timbrell JA. 1982. Studies on hydrazine hepatotoxicity. 1. Pathological findings. J Toxicol Environ Health. 10:941–953.
   PubMed Web of Science ®Google Scholar
• Sridevi JP, Anantaraju HS, Kulkarni P, Yogeeswari P, Sriram D. 2014. Optimization and validation of Mycobacterium marinum-induced adult zebrafish model for evaluation of oral anti-tuberculosis drugs. Int J Mycobacteriol. 3:259–267.
   PubMedGoogle Scholar
• Swaim LE, Connolly LE, Volkman HE, Humbert O, Born DE, Ramakrishnan L. 2006. Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity. Infect Immun. 74:6108–6117.
   PubMed Web of Science ®Google Scholar
• Swinney DC. 2013. Phenotypic vs. target-based drug discovery for first-in-class medicines. Clin Pharmacol Ther. 93:299–301.
   PubMed Web of Science ®Google Scholar
• Terriente J, Pujades C. 2013. Use of zebrafish embryos for small molecule screening related to cancer. Dev Dyn. 242:97–107.
   PubMed Web of Science ®Google Scholar
• Tobin DM, Ramakrishnan L. 2008. Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis. Cell Microbiol. 10:1027–1039.
   PubMed Web of Science ®Google Scholar
• Tokunaga Y, Shirouzu M, Sugahara R, Yoshiura Y, Kiryu I, Ototake M, Nagasawa T, Somamoto T, Nakao M. 2017. Comprehensive validation of T- and B-cell deficiency in rag1-null zebrafish: implication for the robust innate defense mechanisms of teleosts. Sci Rep. 7:7536.
   PubMed Web of Science ®Google Scholar
• van der Sar AM, Abdallah AM, Sparrius M, Reinders E, Vandenbroucke-Grauls CM, Bitter W. 2004. Mycobacterium marinum strains can be divided into two distinct types based on genetic diversity and virulence. Infect Immun. 72:6306–6312.
   PubMed Web of Science ®Google Scholar
• van Leeuwen LM, van der Kuip M, Youssef SA, de Bruin A, Bitter W, van Furth AM, van der Sar AM. 2014. Modeling tuberculous meningitis in zebrafish using Mycobacterium marinum. Dis Model Mech. 7:1111–1122.
   PubMed Web of Science ®Google Scholar
• Vashisht R, Brahmachari SK. 2015. Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis. J Transl Med. 13:83.
   PubMed Web of Science ®Google Scholar
• Verstraelen S, Peers B, Maho W, Hollanders K, Remy S, Berckmans P, Covaci A, Witters H. 2016. Phenotypic and biomarker evaluation of zebrafish larvae as an alternative model to predict mammalian hepatotoxicity. J Appl Toxicol. 36:1194–1206.
   PubMed Web of Science ®Google Scholar
• Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F. 2012. Cellular and molecular mechanisms of metformin: an overview. Clin Sci. 122:253–270.
   PubMed Web of Science ®Google Scholar
• WHO. 2017. Global Tuberculosis Report 2017.
   Google Scholar
• Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, Hoyng SA, Lin HY, Bloch KD, Peterson RT. 2008. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol. 4:33–41.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Han L, He Q, Chen W, Sun C, Wang X, Chen X, Wang R, Hsiao C-D, Liu K. 2017. A rapid assessment for predicting drug-induced hepatotoxicity using zebrafish. J Pharmacol Toxicol Methods. 84:102–110.
   PubMed Web of Science ®Google Scholar
• Zhang F, Qin W, Zhang JP, Hu CQ. 2015. Antibiotic toxicity and absorption in zebrafish using liquid chromatography-tandem mass spectrometry. PLoS One. 10:e0124805.
   PubMed Web of Science ®Google Scholar
• Zhuo H, Jin H, Peng H, Huang H. 2016. Distribution, pharmacokinetics and primary metabolism model of tramadol in zebrafish. Mol Med Rep. 14:5644–5652.
   PubMed Web of Science ®Google Scholar
• Zon LI, Peterson RT. 2005. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov. 4:35–44.
   PubMed Web of Science ®Google Scholar
• Zou Y, Zhang Y, Han L, He Q, Hou H, Han J, Wang X, Li C, Cen J, Liu K. 2017. Oxidative stress-mediated developmental toxicity induced by isoniazide in zebrafish embryos and larvae. J Appl Toxicol. 37:842–852.
   PubMed Web of Science ®Google Scholar